Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
svetlo pulzné intenzívne active
active optical systems ltd 11 shoham st. petach-tikva izrael -
Slovensko -
slovenčina -
myHealthbox
husar active plus
bayer ag - suspenzný koncentrát - idosulfuron-methyl-sodium 10 g/l; 2,4-d 2-ehe 300g/l; thiencarbazone-methyl 7,5 g/l; mefenpyr-diethyl (safener) 30 g/l
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
nurofen pre deti active
reckitt benckiser (czech republic), spol. s r.o. , Česká republika - ibuprofén - 29 - antirheumatica, antiphlogistica, antiuratica
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
nasal duo active 1,0/50 mg/ml
teva pharmaceuticals slovakia s.r.o., slovensko - xylometazolín - 69 - otorhinolaryngologica
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
nasal duo active 0,5/50 mg/ml
teva pharmaceuticals slovakia s.r.o., slovensko - xylometazolín - 69 - otorhinolaryngologica
Slovensko -
slovenčina -
myHealthbox
husar active plus
bayer ag - suspenzný koncentrát - idosulfuron-methyl-sodium 10 g/l; 2,4-d 2-ehe 300g/l; thiencarbazone-methyl 7,5 g/l; mefenpyr-diethyl (safener) 30 g/l
Európska únia -
slovenčina -
EMA (European Medicines Agency)
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
irinotecan medac 20 mg/ml
medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - irinotekán - 44 - cytostatica